Short Information | Taiwan Liposome Company Ltd. (NASDAQ:TLC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 32,812 |
Total Actual Volume | 293,171 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,641 |
Average Short Percentage | 10.09% |
Is there a TLC Short Squeeze or Breakout about to happen?
See the TLC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-24-2021 | $6.82 | $7.01 | $7.01 | $6.82 | 19,223 | 1,418 | 7.38% |
09-23-2021 | $6.85 | $7.08 | $7.08 | $6.85 | 10,363 | 1,445 | 13.94% |
09-22-2021 | $6.9 | $6.9287 | $7.0726 | $6.8201 | 7,851 | 1,171 | 14.92% |
09-21-2021 | $7 | $6.9449 | $7 | $6.82 | 6,828 | 1,026 | 15.03% |
09-20-2021 | $7.3 | $7.1 | $7.3 | $6.9796 | 9,542 | 1,435 | 15.04% |
09-17-2021 | $6.95 | $7.25 | $7.25 | $6.65 | 22,269 | 4,563 | 20.49% |
09-16-2021 | $7.18 | $7.0406 | $7.2487 | $6.95 | 15,203 | 3,287 | 21.62% |
09-15-2021 | $7.08 | $7.24 | $7.35 | $7.08 | 4,462 | 206 | 4.62% |
09-14-2021 | $7.1 | $7.1596 | $7.1596 | $7 | 8,580 | 654 | 7.62% |
09-13-2021 | $7.33 | $7 | $7.33 | $7 | 28,799 | 7,910 | 27.47% |
09-10-2021 | $7.0001 | $7.32 | $7.32 | $7.0001 | 15,001 | 2,905 | 19.37% |
09-09-2021 | $7.1 | $7 | $7.1 | $7 | 10,352 | 252 | 2.43% |
09-08-2021 | $7.25 | $7.15 | $7.3307 | $7.1 | 8,097 | 8 | 0.1% |
09-07-2021 | $7.59 | $7.35 | $7.59 | $7.28 | 2,687 | 20 | 0.74% |
09-03-2021 | $7.69 | $7.53 | $7.69 | $7.4901 | 11,544 | 381 | 3.3% |
09-01-2021 | $7.52 | $7.6273 | $7.7 | $7.4701 | 8,845 | 470 | 5.31% |
08-31-2021 | $7.27 | $7.44 | $7.54 | $7.27 | 76,167 | 3,796 | 4.98% |
08-30-2021 | $7.21 | $7.2 | $7.23 | $7.1 | 5,705 | 350 | 6.13% |
08-25-2021 | $7.1 | $7.07 | $7.1 | $7.04 | 8,225 | 14 | 0.17% |
08-24-2021 | $7 | $7.08 | $7.09 | $6.98 | 13,428 | 1,501 | 11.18% |
News, Short Squeeze, Breakout and More Instantly...
Taiwan Liposome Company Ltd. Company Name:
TLC Stock Symbol:
NASDAQ Market:
Taiwan Liposome Company Ltd. Website:
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed findings from the Phase 3 clinical trial of TLC599 at the American College of Rheumatology (ACR) Annual...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the Abstract Sele...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it has entered a commercialization agreem...